Combination of carboplatin and intermittent normobaric hyperoxia synergistically suppresses benzo[a]pyrene-induced lung cancer
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: We explored the effects of intermittent normobaric hyperoxia alone or combined with chemotherapy on the growth, general morphology, oxidative stress, and apoptosis of benzo[a]pyrene (B[a]P)-induced lung tumors in mice. Methods: Female A/J mice were given a single dose of B[a]P and randomized into four groups: control, carboplatin (50 mg/kg intraperitoneally), hyperoxia (95% fraction of inspired oxygen), and carboplatin and hyperoxia. Normobaric hyperoxia (95%) was applied for 3 hours each day from weeks 21 to 28. Tumor load was determined as the average total tumor numbers and volumes. Several markers of oxidative stress and apoptosis were evaluated. Results: Intermittent normobaric hyperoxia combined with chemotherapy reduced the tumor number by 59% and the load by 72% compared with the control B[a]P group. Intermittent normobaric hyperoxia, either alone or combined with chemotherapy, decreased the levels of superoxide dismutase and glutathione and increased the levels of catalase and 8-hydroxydeoxyguanosine. The Bax/Bcl- 2 mRNA ratio, caspase 3 level, and number of transferase-mediated dUTP nick end-labeling positive cells increased following treatment with hyperoxia with or without chemotherapy. Conclusions: Intermittent normobaric hyperoxia was found to be tumoricidal and thus may serve as an adjuvant therapy for lung cancer. Oxidative stress and its effects on DNA are increased following exposure to hyperoxia and even more with chemotherapy, and this may lead to apoptosis of lung tumors.
Abstract
Background/Aims: We explored the effects of intermittent normobaric hyperoxia alone or combined with chemotherapy on the growth, general morphology, oxidative stress, and apoptosis of benzo[a]pyrene (B[a]P)-induced lung tumors in mice. Methods: Female A/J mice were given a single dose of B[a]P and randomized into four groups: control, carboplatin (50 mg/kg intraperitoneally), hyperoxia (95% fraction of inspired oxygen), and carboplatin and hyperoxia. Normobaric hyperoxia (95%) was applied for 3 hours each day from weeks 21 to 28. Tumor load was determined as the average total tumor numbers and volumes. Several markers of oxidative stress and apoptosis were evaluated. Results: Intermittent normobaric hyperoxia combined with chemotherapy reduced the tumor number by 59% and the load by 72% compared with the control B[a]P group. Intermittent normobaric hyperoxia, either alone or combined with chemotherapy, decreased the levels of superoxide dismutase and glutathione and increased the levels of catalase and 8-hydroxydeoxyguanosine. The Bax/Bcl- 2 mRNA ratio, caspase 3 level, and number of transferase-mediated dUTP nick end-labeling positive cells increased following treatment with hyperoxia with or without chemotherapy. Conclusions: Intermittent normobaric hyperoxia was found to be tumoricidal and thus may serve as an adjuvant therapy for lung cancer. Oxidative stress and its effects on DNA are increased following exposure to hyperoxia and even more with chemotherapy, and this may lead to apoptosis of lung tumors.
참고문헌 (31)
- Hockel M, "Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects", J Natl Cancer Inst, 93, pp.266~276 (2001)[DOI]
- Rofstad EK, "Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination", Int J Cancer, 127, pp.1535~1546 (2010)[DOI]
- Brizel DM, "The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation", Br J Cancer, 72, pp.1120~1124 (1995)[DOI]
- Kalns J, "The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer", Anticancer Res, 18, pp.363~367 (1998)
- Kunugita N, "Radiotherapy after hyperbaric oxygenation improves radioresponse in experimental tumor models", Cancer Lett, 164, pp.149~154 (2001)[DOI]
- Al-Waili NS, "Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy", Med Sci Monit, 11, pp.RA279~RA289 (2005)
- Takiguchi N, "Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: evaluation of antitumor effect and measurement of 5-FU in individual organs", Cancer Chemother Pharmacol, 47, pp.11~14 (2001)[DOI]
- Stuhr LE, "Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors", Cancer Lett, 210, pp.35~40 (2004)[DOI]
- Raa A, "Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumors", BMC Cancer, 7, pp.23~ (2007)[DOI]
- Lindenschmidt RC, "Modification of lung tumor growth by hyperoxia", Carcinogenesis, 7, pp.1581~1586 (1986)[DOI]
- Margaretten NC, "Effects of hyperoxia on growth characteristics of metastatic murine tumors in the lung", Cancer Res, 48, pp.2779~2783 (1988)
- Schuller HM, "Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the modulating effect of hyperoxia", Cancer Res, 50, pp.1960~1965 (1990)
- Petre PM, "Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of metastatic lung tumors in a rat model", J Thorac Cardiovasc Surg, 125, pp.85~95 (2003)[DOI]
- Gill AL, "Hyperbaric oxygen: its uses, mechanisms of action and outcomes", QJM, 97, pp.385~395 (2004)
- Kallet RH, "Hyperoxic acute lung injury", Respir Care, 58, pp.123~141 (2013)[DOI]
- Konsavage WM, "Hyperoxia-induced activation of the integrated stress response in the newborn rat lung", Am J Physiol Lung Cell Mol Physiol, 302, pp.L27~L35 (2012)[DOI]
- Balestra C, "Serum erythropoietin levels in healthy humans after a short period of normobaric and hyperbaric oxygen breathing: the "normobaric oxygen paradox"", J Appl Physiol (1985), 100, pp.512~518 (2006)[DOI]
- Haddad JJ, "Oxygen-sensing mechanisms and the regulation of redox-responsive transcription factors in development and pathophysiology", Respir Res, 3, pp.26~ (2002)[DOI]
- Narkowicz CK, "Hyperbaric oxygen therapy increases free radical levels in the blood of humans", Free Radic Res Commun, 19, pp.71~80 (1993)[DOI]
- Halliwell B, "Role of free radicals and catalytic metal ions in human disease: an overview", Methods Enzymol, 186, pp.1~85 (1990)
- Halliwell B, "Reactive oxygen species in living systems: source, biochemistry, and role in human disease", Am J Med, 91, pp.14S~22S (1991)
- Oberley LW, "Role of superoxide dismutase in cancer: a review", Cancer Res, 39, pp.1141~1149 (1979)
- Michiels C, "Importance of Se-glutathione peroxidase, catalase, and Cu", Zn-SOD for cell survival against oxidative stress, 1994, pp.17, 235~248
- Chance B, "Hydroperoxide metabolism in mammalian organs", Physiol Rev, 59, pp.527~605 (1979)[DOI]
- Jones DP, "Metabolism of hydrogen peroxide in isolated hepatocytes: relative contributions of catalase and glutathione peroxidase in decomposition of endogenously generated H2O2", Arch Biochem Biophys, 210, pp.505~516 (1981)[DOI]
- Dalle-Donne I, "Protein carbonyl groups as biomarkers of oxidative stress", Clin Chim Acta, 329, pp.23~38 (2003)[DOI]
- Cheng KC, "8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions", J Biol Chem, 267, pp.166~172 (1992)
- Finkel T, "Oxidant signals and oxidative stress", Curr Opin Cell Biol, 15, pp.247~254 (2003)[DOI]
- Hockenbery D, "Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death", Nature, 348, pp.334~336 (1990)[DOI]
- Oltvai ZN, "Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death", Cell, 74, pp.609~619 (1993)[DOI]
- Porter AG, "Emerging roles of caspase-3 in apoptosis", Cell Death Differ, 6, pp.99~104 (1999)[DOI]